Sexual and Reproductive Health in HIV Serodiscordant Couples

Christian C. Makwe, Osato F. Giwa-Osagie


Serodiscordant couples are a significant source of new HIV infection in sub-Sahara Africa. The prevention of HIV transmission to the uninfected partner should be an integral part of their health care. Serodiscordant couples desire pregnancy, treatment for infertility, effective family planning services, sexual health screening, and so on. This paper reviews the sexual and reproductive health needs of heterosexual serodiscordant couples, based on current evidence and recommendations. Afr J Reprod Health 2013 (Special Edition); 17[4]: 99-106).


Keywords: HIV, Serodiscordant couple, Conception, Contraception, infertility




Les couples sérodiscordants sont une source importante de nouvelles infections du VIH en Afrique sub-saharienne. La prévention de la transmission du VIH au partenaire non infecté doit être une partie intégrante de leurs soins de santé. Les couples sérodiscordants désirent une grossesse, le traitement de la stérilité, des services de planification familiale efficaces, le dépistage de la santé sexuelle et ainsi de suite. Ce document passe en revue les besoins en matière de santé sexuelle et reproductive des couples hétérosexuels sérodiscordants, fondées sur des preuves et des recommandations en vigueur. Afr J Reprod Health 2013 (Special Edition); 17[4]: 99-106).


Mots-clés: VIH, couple sérodiscordants, conception, contraception, l'infertilité 

Full Text:



A cluster of Kaposi's sarcoma and Pneumocystis carinii pneumonia among homosexual male residents of Los Angeles and Orange Counties, California. MMWR Morb Mortal Wkly Rep 1982; 31(23):305-7.

Pneumocystis pneumonia--Los Angeles. MMWR Morb Mortal Wkly Rep 1981; 30(21):250-2.

Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men--New York City and California. MMWR Morb Mortal Wkly Rep 1981; 30(25):305-8.

Francioli P, Vogt M, Schadelin J, Clement F, Russi E, Delacretaz F, et al. [Acquired immunologic deficiency syndrome, opportunistic infections and homosexuality. Presentation of 3 cases studied in

Switzerland]. Schweiz Med Wochenschr 1982; 112(47):1682-7.

Gerstoft J, Malchow-Moller A, Bygbjerg I, Dickmeiss E, Enk C, Halberg P, et al. Severe acquired immunodeficiency in European homosexual men. Br Med J (Clin Res Ed) 1982;285(6334):17-9.

UNAIDS report on the global AIDS Epidemic. Geneva: UNAIDS, 2012.

Dunkle KL, Stephenson R, Karita E, Chomba E, Kayitenkore K, Vwalika C, et al. New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data. Lancet 2008;371(9631):218391.

Chemaitelly H, Cremin I, Shelton J, Hallett TB, AbuRaddad LJ. Distinct HIV discordancy patterns by epidemic size in stable sexual partnerships in subSaharan Africa. Sex Transm Infect 2012;88(1):51-7.

Lurie MN, Williams BG, Zuma K, Mkaya-Mwamburi D, Garnett GP, Sweat MD, et al. Who infects whom? HIV-1 concordance and discordance among migrant and non-migrant couples in South Africa. AIDS 2003;17(15):2245-52.

Sagay AS, Onakewhor J, Galadanci H, Emuveyan EE. HIV status of partners of HIV positive pregnant women in different regions of Nigeria: matters arising. Afr J Med Med Sci 2006;35 Suppl:125-9.

Carpenter LM, Kamali A, Ruberantwari A, Malamba SS, Whitworth JA. Rates of HIV-1 transmission within marriage in rural Uganda in relation to the HIV serostatus of the partners. AIDS 1999;13(9):1083-9.

Eyawo O, de Walque D, Ford N, Gakii G, Lester RT, Mills EJ. HIV status in discordant couples in subSaharan Africa: a systematic review and metaanalysis. Lancet Infect Dis 2010;10(11):770-7.

Allen S, Meinzen-Derr J, Kautzman M, Zulu I, Trask S, Fideli U, et al. Sexual behavior of HIV discordant couples after HIV counseling and testing. AIDS 2003;17(5):733-40.

Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo N, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 2010;362(5):427-39.

Bishop MF, Foreit K. Sero-discordant Couples in subSahara Africa: What Do Survey Data Tell Us? Washington DC: Future Group, Health Policy

Initiative, Task order 1., 2010.

Allen S, Tice J, Van de Perre P, Serufilira A, Hudes E, Nsengumuremyi F, et al. Effect of sero-testing with counselling on condom use and seroconversion among HIV discordant couples in Africa. BMJ


Hira SK, Nkowane BM, Kamanga J, Wadhawan D, Kavindele D, Macuacua R, et al. Epidemiology of human immunodeficiency virus in families in Lusaka, Zambia. J Acquir Immune Defic Syndr 1990;3(1):83-

Guthrie BL, de Bruyn G, Farquhar C. HIV-1-discordant couples in sub-Saharan Africa: explanations and implications for high rates of discordancy. Curr HIV Res 2007;5(4):416-29.

Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, Wabwire-Mangen F, et al. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001;357(9263):1149-53.

Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, Laeyendecker O, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005;191(9):1403-9.

Fakoya A, Lamba H, Mackie N, Nandwani R, Brown A, Bernard E, et al. British HIV Association, BASHH

and FSRH guidelines for the management of the sexual and reproductive health of people living with HIV infection 2008. HIV Med 2008;9(9):681-720.

Roth DL, Stewart KE, Clay OJ, van Der Straten A, Karita E, Allen S. Sexual practices of HIV discordant and concordant couples in Rwanda: effects of a testing and counselling programme for men. Int J STD AIDS 2001;12(3):181-8.

Muldoon KA, Shannon K, Khanakwa S, Ngolobe M, Birungi J, Zhang W, et al. Gendered HIV risk patterns among polygynous sero-discordant couples in Uganda. Cult Health Sex 2011;13(8):933-44.

Ezeanochie M, Olagbuji B, Ande A, Oboro V. Fertility preferences, condom use, and concerns among HIVpositive women in sero-discordant relationships in the era of antiretroviral therapy. Int J Gynaecol Obstet 2009;107(2):97-8.

Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000;342(13):921-9.

Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load antiretrovial treatment: systemiv review and metaanalysis. AIDS 2009;23:1397-1404.

Cohen MS, Chen YQ, McCauley M, Gamble T,

Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365(6):493-505.

Sturmer M, Doerr HW, Berger A, Gute P. Is transmission of HIV-1 in non-viraemic sero-discordant couples possible? Antivir Ther 2008;13(5):729-32.

Sadiq ST, Taylor S, Kaye S, Bennett J, Johnstone R, Byrne P, et al. The effects of antiretroviral therapy on HIV-1 RNA loads in seminal plasma in HIV-positive patients with and without urethritis. AIDS 2002;16(2):219-25.

Winter AJ, Taylor S, Workman J, White D, Ross JD, Swan AV, et al. Asymptomatic urethritis and detection of HIV-1 RNA in seminal plasma. Sex Transm Infect 1999;75(4):261-3.

Kamenga M, Ryder RW, Jingu M, Mbuyi N, Mbu L, Behets F, et al. Evidence of marked sexual behavior change associated with low HIV-1 seroconversion in 149 married couples with discordant HIV-1 serostatus: experience at an HIV counselling center in Zaire. AIDS 1991;5(1):61-7.

Mmeje O, Cohen CR, Cohan D. Evaluating safer conception options for HIV-sero-discordant couples (HIV-infected female/HIV-uninfected male): a closer look at vaginal insemination. Infect Dis Obstet Gynecol 2012;2012:587651.

Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalugoda F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007;369(9562):657-66.

Bailey RC, Moses S, Parker CB, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet


World Health Organisation. Antiretroviral for HIV infection in adults and adolescents. Recommendation for a public health approach: 2010 revision. Geneva 2010.

World Health Organisation. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Recommendations for a public health approach 2010 version, Geneva 2010.

World Health Organisation. Guidance on couples HIV testing and counselling - including antiretroviral therapy for treatment and prevention in serodiscordant couples. Geneva 2012.

Okwundu CI, Uthman OA, Okoromah CA. Antiretroviral pre-exposure prophylaxis (PrEP) for preventing HIV in high-risk individuals. Cochrane Database Syst Rev 2012;7:CD007189.

Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med 2012; 367(5):423-34.

Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med 2012;367(5):399-410.

Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med 2012;367(5):411-22.

World Health Organisation. Guidance on oral preexposure prophylaxis (PrEP) for sero-discordant couples, men and transgender women who have sex with men at high risk of HIV: recommendations for use in the context of demonstration projects. Geveva 2012.

Agboghoroma OC, Giwa-Osagie OF. Management of Infertility in HIV infected couples: A Review. Afr J Reprod Health 2012;16(4):13-20.

Barreiro P, del Romero J, Leal M, Hernando V, Asencio R, de Mendoza C, et al. Natural pregnancies in HIVsero-discordant couples receiving successful antiretroviral therapy. J Acquir Immune Defic Syndr 2006;43(3):324-6.

Barreiro P, Duerr A, Beckerman K, Soriano V. Reproductive options for HIV-sero-discordant couples. AIDS Rev 2006;8(3):158-70.

Matthews LT, Smit JA, Cu-Uvin S, Cohan D. Antiretrovirals and safer conception for HIV-sero- discordant couples. Curr Opin HIV AIDS 2012; 7(6):569-78.

Bujan L, Hollander L, Coudert M, Gilling-Smith C, Vucetich A, Guibert J, et al. Safety and efficacy of sperm washing in HIV-1-serodiscordant couples where the male is infected: results from the European CREAThE network. AIDS 2007;21(14):1909-14.

Mugo NR, Heffron R, Donnell D, Wald A, Were EO, Rees H, et al. Increased risk of HIV-1 transmission in pregnancy: a prospective study among African HIV-1serodiscordant couples. AIDS 2011;25(15):1887-95.

Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, Burchett SK, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med 1999; 341(6):394-402.

Birkhead GS, Pulver WP, Warren BL, Hackel S, Rodriguez D, Smith L. Acquiring human immunodeficiency virus during pregnancy and mother-to-child transmission in New York: 20022006. Obstet Gynecol 2010;115(6):1247-55.

World Health Organisation. Delivering HIV test results and messages for re-testing and counselling in adults. Geneva 2010.

Prendergast A, Tudor-Williams G, Jeena P, Burchett S, Goulder P. International perspectives, progress, and future challenges of paediatric HIV infection. Lancet 2007;370(9581):68-80.

The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a metaanalysis of 15 prospective cohort studies. The International Perinatal HIV Group. N Engl J Med 1999;340(13):977-87.

Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet 1999; 353(9158): 1035-9.

Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of hormonal contraception among women at high risk for HIV infection or infected with HIV. MMWR Morb Mortal Wkly Rep 2012;61(24):449-52.

Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E, et al. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 2011;12(1):19-26.

World Health Organisation. Hormonal contraception and HIV: technical statement Geneva 2012.


  • There are currently no refbacks.